NCT07246590Phase 3Active not recruiting

Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

Study sponsor: Verrica Pharmaceuticals Inc. · VRCA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-11Estimated
Enrollment · participants302Actual
Source updated2026-10-23Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 300 participants (planned). After: 302 participants (actual).

Primary completion date changed

Before: Jun 2027. After: Nov 2026.

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source